National Vision Holdings Price to Sales Ratio 2015-2023 | EYE

Historical PS ratio values for National Vision Holdings (EYE) over the last 10 years. The current P/S ratio for National Vision Holdings as of April 15, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
National Vision Holdings P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-04-15 19.22 0.74
2023-12-31 20.93 $25.82 0.81
2023-09-30 16.18 $25.65 0.63
2023-06-30 24.29 $25.18 0.96
2022-12-31 38.76 $24.03 1.61
2022-09-30 32.65 $23.16 1.41
2022-06-30 27.50 $22.24 1.24
2022-03-31 43.57 $21.62 2.02
2021-12-31 47.99 $21.62 2.22
2021-09-30 56.77 $22.65 2.51
2021-06-30 51.13 $23.07 2.22
2021-03-31 43.83 $20.59 2.13
2020-12-31 45.29 $21.13 2.14
2020-09-30 38.24 $20.84 1.83
2020-06-30 30.52 $19.97 1.53
2023-03-31 18.84 $22.03 0.86
2020-03-31 19.42 $21.20 0.92
2019-12-31 32.43 $21.15 1.53
2019-09-30 24.07 $20.73 1.16
2019-06-30 30.73 $20.30 1.51
2019-03-31 31.43 $19.98 1.57
2018-12-31 28.17 $19.56 1.44
2018-09-30 45.14 $20.24 2.23
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.505B $2.126B
National Vision Holdings, Inc. is one of the leading and rapidly growing optical retailers in the U.S. It provides budget-friendly eye exams, eyeglasses and contact lenses to low-income consumers and aims at making eye care and eyewear reasonable for all Americans. The company operates through a diverse portfolio of retail stores across brands and consumer websites. The company uses third-party carriers to transport all products from the distribution centers to the destination. It operates through 2 reportable segments. Owned & host segment includes the company's owned brands, namely, America's Best and Eyeglass World along with its Vista Optical locations in Fred Meyer stores. National Vision also provides affordable eye care products and services to American military service members within the owned & host segment. Legacy segment comprises National Vision's old strategic collaboration with Walmart to run to Vision Centers in certain Walmart stores.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $188.944B 24.52
Stryker (SYK) United States $129.029B 31.99
Medtronic (MDT) Ireland $106.531B 15.08
Boston Scientific (BSX) United States $98.941B 32.90
EssilorLuxottica (ESLOY) France $97.450B 0.00
Lonza Group Ag (LZAGY) Switzerland $43.229B 0.00
Haleon (HLN) United Kingdom $36.803B 28.79
ResMed (RMD) United States $27.225B 27.22
Zimmer Biomet Holdings (ZBH) United States $25.477B 16.40
Terumo (TRUMY) Japan $24.641B 34.80
Baxter (BAX) United States $20.333B 14.83
Koninklijke Philips (PHG) Netherlands $18.954B 15.12
Insulet (PODD) United States $12.180B 63.95
Smith & Nephew SNATS (SNN) United Kingdom $10.404B 0.00
Demant (WILYY) Denmark $10.167B 0.00
Bio-Rad Laboratories (BIO) United States $8.567B 25.52
BellRing Brands (BRBR) United States $7.140B 38.39
Haemonetics (HAE) United States $4.311B 22.05
Lantheus Holdings (LNTH) United States $4.130B 10.66
Perrigo (PRGO) Ireland $4.083B 11.68
GN Store Nord (GNNDY) Denmark $3.675B 23.80
Prestige Consumer Healthcare (PBH) United States $3.383B 15.99
Envista Holdings (NVST) United States $3.289B 12.51
QuidelOrtho (QDEL) United States $2.772B 10.06
Green Thumb Industries (GTBIF) United States $2.630B 83.33
Neogen (NEOG) United States $2.601B 25.02
ICU Medical (ICUI) United States $2.366B 17.66
TG Therapeutics (TGTX) United States $2.173B 703.50
Maravai LifeSciences Holdings (MRVI) United States $2.039B 0.00
Owens & Minor (OMI) United States $1.914B 18.38
Verano Holdings (VRNOF) United States $1.710B 0.00
Agios Pharmaceuticals (AGIO) United States $1.644B 0.00
InMode (INMD) Israel $1.486B 7.69
LeMaitre Vascular (LMAT) United States $1.437B 47.74
AdaptHealth (AHCO) United States $1.313B 9.88
Warby Parker (WRBY) United States $1.282B 0.00
AtriCure (ATRC) United States $1.108B 0.00
MacroGenics (MGNX) United States $1.060B 0.00
BioLife Solutions (BLFS) United States $0.710B 0.00
VAREX IMAGING (VREX) United States $0.706B 15.26
Cresco Labs (CRLBF) United States $0.691B 0.00
Evolus (EOLS) United States $0.689B 0.00
Quanterix (QTRX) United States $0.653B 0.00
Canopy Growth (CGC) Canada $0.636B 0.00
Valneva SE (VALN) France $0.590B 0.00
Jin Medical (ZJYL) China $0.541B 0.00
Phibro Animal Health (PAHC) United States $0.535B 11.59
TerrAscend (TSNDF) Canada $0.524B 0.00
PetIQ (PETQ) United States $0.476B 17.78
Biote (BTMD) United States $0.439B 4.18
ZimVie (ZIMV) United States $0.428B 26.23
OraSure Technologies (OSUR) United States $0.414B 6.85
Zynex (ZYXI) United States $0.385B 44.30
Surmodics (SRDX) United States $0.376B 40.65
Aurora Cannabis (ACB) Canada $0.343B 0.00
Viemed Healthcare (VMD) United States $0.315B 31.31
Cerus (CERS) United States $0.314B 0.00
Sanara MedTech (SMTI) United States $0.278B 0.00
TriSalus Life Sciences (TLSI) United States $0.250B 0.00
Utah Medical Products (UTMD) United States $0.245B 14.95
Veru (VERU) United States $0.224B 0.00
Omeros (OMER) United States $0.196B 0.00
Organigram Holdings (OGI) Canada $0.194B 0.00
Capricor Therapeutics (CAPR) United States $0.185B 0.00
Ayr Wellness (AYRWF) United States $0.182B 0.00
High Tide (HITI) Canada $0.178B 0.00
Quipt Home Medical (QIPT) United States $0.161B 0.00
Eagleford Energy (GRUSF) United States $0.135B 68.00
FitLife Brands (FTLF) United States $0.134B 21.52
Jushi Holdings (JUSHF) United States $0.132B 0.00
Allurion Technologies (ALUR) United States $0.114B 0.00
InterCure (INCR) Israel $0.112B 18.85
Cellectar Biosciences (CLRB) United States $0.107B 0.00
Fonar (FONR) United States $0.106B 9.15
Safety Shot (SHOT) United States $0.098B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.098B 0.00
MariMed (MRMD) United States $0.098B 0.00
Brainsway (BWAY) Israel $0.088B 0.00
Chimerix (CMRX) United States $0.082B 0.00
Zevia PBC (ZVIA) United States $0.070B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.068B 4.41
United Health Products (UEEC) United States $0.052B 0.00
Apyx Medical (APYX) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.047B 0.00
Rockwell Medical (RMTI) United States $0.045B 0.00
Bright Green (BGXX) United States $0.041B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.035B 13.75
Modular Medical (MODD) United States $0.034B 0.00
Exagen (XGN) United States $0.025B 0.00
Nephros (NEPH) United States $0.021B 0.00
FSD PHARMA (HUGE) Canada $0.021B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Agape ATP (ATPC) $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
GlucoTrack (GCTK) United States $0.011B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 71.73
ProSomnus (OSA) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00